jardiance glp 1 Eli Lilly, Boehringer hit FDA roadblock in quest to repurpose for Type diabetes Jardiance vs Mounjaro 2026: Heart

SKK is the holder of the Evelyn Wyrzykowski Research Chair in Cardiology, Section of Cardiology, Department of Internal Medicine, University of Manitoba

So far, Novo is furthest ahead in developing an obesity pill

One of the hallmarks in several neurodegenerative disorders in the progressive loss of glucose uptake in the brain, and among other effects, we saw that those with T2D had lower glucose uptake compared to overweight/obesity and the controls

Were seeing widespread use of these medications among women of childbearing age, but very little evidence that contraception is being considered as part of routine care

Attempt to re-start the GLP-1 or GIP/GLP-1 receptor agonist as quickly as they are available

This convergence of intracellular signaling architecture despite divergent extracellular binding mechanisms is a key insight from the orforglipron structural studies